Advertisement
Screener

BIOMERICA INC (BMRA) Stock Issued During Period, Value, New Issues

BIOMERICA INC Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • BIOMERICA INC stock issued during period, value, new issues for the quarter ending 2026-05-31 was $372.00K.
  • BIOMERICA INC stock issued during period, value, new issues for the quarter ending 2026-02-28 was $60.00K, a 95.86% decline year-over-year.
  • BIOMERICA INC stock issued during period, value, new issues for the quarter ending 2025-11-30 was $483.00K, a 14.81% decline year-over-year.
  • BIOMERICA INC stock issued during period, value, new issues for the quarter ending 2025-08-31 was $912.00K.
  • BIOMERICA INC stock issued during period, value, new issues for fiscal 2026 was $1.83M, a 9.33% decline from fiscal 2025.
  • BIOMERICA INC stock issued during period, value, new issues for fiscal 2025 was $2.02M.
  • BIOMERICA INC stock issued during period, value, new issues for fiscal 2023 was $1.96M, a 15.36% decline from fiscal 2022.
  • BIOMERICA INC stock issued during period, value, new issues for fiscal 2022 was $2.32M, a 129.07% increase from fiscal 2021.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2026-05-31$372.00K
derived: 10-K 12 month − 3 quarters · filed 2026-08-31
$1.83M
10-K · filed 2026-08-31
2026-02-28$60.00K
10-Q · filed 2026-04-13
2025-11-30$483.00K
10-Q · filed 2026-04-13
2025-08-31$912.00K
10-Q · filed 2026-04-13
2025-05-31$2.02M
10-K · filed 2026-08-31
2025-02-28$1.45M
10-Q · filed 2026-04-13
2024-11-30$567.00K
10-Q · filed 2026-04-13
2023-05-31$1.96M
10-K · filed 2024-08-28
2023-02-28$25.00K
10-Q · filed 2024-04-12
$1.96M
derived: sum of 4 quarters · filed 2024-04-12
2022-11-30$173.00K
10-Q · filed 2024-04-12
$2.57M
derived: sum of 4 quarters · filed 2024-04-12
2022-08-31$1.76M
10-Q · filed 2024-04-12
$3.28M
derived: sum of 4 quarters · filed 2024-04-12
2022-05-31-$160.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25
$2.32M
10-K · filed 2023-08-25
2022-02-28$633.04K
10-Q · filed 2023-04-14
$2.32M
derived: sum of 4 quarters · filed 2023-04-14
2021-11-30$883.41K
10-Q · filed 2023-04-14
2021-08-31$800.71K
10-Q · filed 2023-04-14
2021-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29
$1.01M
10-K · filed 2022-08-29
2020-05-31$9.87M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14
$10.23M
10-K/A · filed 2021-10-14
2020-02-29$58.57K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-14
$1.13M
derived: sum of 4 quarters · filed 2021-04-14
2019-11-30$195.08K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-14
2019-08-31$112.61K
10-Q · filed 2019-10-15
2019-05-31$764.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31
$1.78M
10-K · filed 2020-08-31
2018-05-31$1.28M
10-K · filed 2019-08-29
2016-05-31$995.98K
10-K · filed 2016-08-29
2014-05-31$250.00K
10-K · filed 2015-08-31
2013-05-31$250.00K
10-K · filed 2014-08-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92